At a glance
ClinicalIndex Comparison RecordN/ACompleted· 332 enrolled
Drug / intervention
CT-FFRother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Diagnostic Performance of On-site Automatic Coronary Computed Tomography Angiography-derived Fractional Flow Reserve
In Brief
An observational study evaluating CT-FFR for Coronary Artery Disease. Completed, enrolled 332 participants across 1 site.
Detailed Summary
The current study evaluated the diagnostic performance for myocardial ischemia of on-site automatic CCTA-derived FFR (CT-FFR) using a commercially available workstation as compared with invasive FFR as a reference. The diagnostic performance of CT-FFR was compared to that of CCTA diameter stenosis.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease
CountriesSouth Korea
Timeline
N/ACompletedFinished
2023202420252026
Enrollment StartMay 2022
Primary CompletionJul 2023
Study CompletionOct 2023
First PostedDec 2023
TodayJul 2026
First PostedDec 1, 2023
Enrollment StartMay 26, 2022
Primary CompletionJul 30, 2023
Study CompletionOct 31, 2023
TodayJul 1, 2026
Enrollment to primary: 1.2 yearsPosted 2.6 years ago
Interventions
CT-FFRother
CT-FFR was calculated using HeartMedi+ 1.0 according to the manufacturer's instructions